The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
RULE NO.:RULE TITLE:
64B15-14.0081Standards for Telemedicine Practice
PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
RULEMAKING AUTHORITY: 459.015(1)(z), FS.
LAW IMPLEMENTED: 459.015(1)(z), FS.
IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Claudia Kemp, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256
THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.
Document Information
- Subject:
- The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
- Purpose:
- The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
- Rulemaking Authority:
- 459.015(1)(z), FS.
- Law:
- 459.015(1)(z), FS.
- Contact:
- Claudia Kemp, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.
- Related Rules: (1)
- 64B15-14.0081. Standards for Telemedicine Practice